Skip to main content
SpringerLink
Log in

Digitalis and Verapamil in Atrial Fibrillation and Flutter

Is Verapamil Now the Preferred Agent?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aronow WS, Landa D, Plasencia G, Wong R, Karlsberg RP, et al. Verapamil in atrial fibrillation and atrial flutter. Clinical Pharmacology and Therapeutics 26: 578–583, 1979

    PubMed  CAS  Google Scholar 

  • Baer FW, Farré J, Ross D, Vanagt EJ, Gorgels AP, et al. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. British Heart Journal 45: 292–298, 1981

    Article  Google Scholar 

  • Belic N, Kramer N, Alisaug A, Singer DH. Digoxin: how effective for heart rate control in ambulatory patients with atrial fibrillation? Circulation 46 (Suppl. 2): II–114, 1972

    Google Scholar 

  • Bellet S. Clinical disorders of the heart beat, pp. 198–199, Lea & Febiger, Philadelphia, 1971

    Google Scholar 

  • Bellet S. Treatment of atrial arrhythmias. In Dreyfus & Likoff (Eds) Cardiac arrhythmias, pp. 171–179, Grune & Stratton, New York, 1973

    Google Scholar 

  • Belz GG, Doering W, Munkes R, Matthews J. Interaction between digoxin and calcium antagonists and antiarrhythmic agents. Clinical Pharmacology and Therapeutaics 33: 410–417, 1983

    Article  CAS  Google Scholar 

  • Bender F. Isoptin zur Behandlung der tachykarden Form des Vorhofflatterns. Medizinische Klinik 62: 634–636, 1967

    PubMed  CAS  Google Scholar 

  • Bender F, Kojima N, Reploh HD, Oelmann G. Behandlung tachykarder Rhythmusstörungen des Herzens durch Beta-Rezeptorenblokade des Atrioventriculargewebes. Medizinische Welt 17: 1120–1123, 1966

    Google Scholar 

  • Bigger JT. Management of arrhythmias. In Braunwald(Ed). Heart disease. A textbook of cardiovascular medicine, pp. 691–743, W.B. Saunders, Philadelphia, 1980

    Google Scholar 

  • Blumgart H. The reaction to exercise of the heart affected by auricular fibrillation. Heart 11: 49–56, 1924

    Google Scholar 

  • Boothby CB, Garrard CS, Pickering D. Verapamil in cardiac arrhythmias. British Medical Journal 2: 660–661, 1972

    Article  Google Scholar 

  • Brichard G, Zimmerman PE. Verapamil in cardiac dysrhythmias during anaesthesia. British Journal of anaesthesia 42: 1005–1011, 1970

    Article  PubMed  CAS  Google Scholar 

  • Brown RW, Goble AJ. Effect of propranolol on exercise tolerance of patients with atrial fibrillation. British Medical Journal 2: 279–280, 1969

    Article  PubMed  CAS  Google Scholar 

  • Chamberlain DA, White RJ, Howard MR, Smith TW. Plasma digoxin concentrations in patients with atrial fibrillation. British Medical Journal 3: 429–432, 1970

    Article  PubMed  CAS  Google Scholar 

  • Carleton RA, Miller PH, Graettinger JS. Effects of ouabain, atropine, and ouabain and atropine on A-V nodal conduction in man. Circulation Research 20: 283–288, 1967

    Article  PubMed  CAS  Google Scholar 

  • Chung EK. Tachyarrhythmias. In Chung (Ed).Cardiac emergency care, pp. 101–155, Lea & Febiger, Philadelphia, 1980

    Google Scholar 

  • Cowan C, Gardiner P, Campbell RWF, Reid DS. Amiodarone versus digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. Circulation (Suppl. 2): II-1746, 1984

  • Curry PVL, Shenasa M. Atrial arrhythmias: clinical concepts. In Mandel (Ed.) Cardiac arrhythmias: their mechanisms, diagnosis, and management, pp. 167–192, 1980

  • David D, DiSegni E, Klein HO, Kaplinsky E. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta-adrenergic blocking agent. American Journal of Cardiology 44: 1378–1381, 1979

    Article  PubMed  CAS  Google Scholar 

  • Dominic J, McAllister Jr RG, Kuo CS, Pratap-Reddy C, Surawicz B. Verapamil plasma levels and ventricular rate response inpatients with atrial fibrillation and flutter. Clinical Pharmacology and Therapeutics 26: 710714, 1979

    Google Scholar 

  • Follath F, Fromer M, Meier P, Vozeh S. Pharmacodynamic comparison of oral and intravenous verapamil in atrial fibrillation. Clinical and Investigational Medicine 3: 49–51, 1980

    CAS  Google Scholar 

  • Gillis RA, Pearle DL, Levitt B. Digitalis: a neuroexcitatory drug. Circulation 52: 739–742, 1975

    Article  PubMed  CAS  Google Scholar 

  • Gold H, Kwit NT, Otto, H, Fox T. Physiological adaptations in cardiac slowing by digitalis and their bearing on problems of digitalization in patients with auricular fibrillation. Journal of Pharmacology and Experimental Therapeutics 67: 224–238, 1939

    CAS  Google Scholar 

  • Goldman S, Probst P, Selzer A, Cohen K. Inefficacy of ‘therapeutic’ serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. American Journal of Cardiology 35: 651–655, 1975

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez R, Scheinman MM. Treatment of supraventricular arrhythmias with intravenous and oral verapamil. Chest 80: 465–470, 1981

    Article  PubMed  CAS  Google Scholar 

  • Goodman DJ, Rossen RM, Cannom, DS, Rider AK, Harrison DC. Effect of digoxin on atrioventricular conduction studies in patients with and without cardiac autonomic innervation. Circulation 51: 251–256, 1975

    Article  PubMed  CAS  Google Scholar 

  • Gotsman MS, Lewis BS, Bakst A, Mitka AS. Verapamil in life-threatening tachyarrhythmias. South African Medical Journal 46: 2017–2019, 1972

    PubMed  CAS  Google Scholar 

  • Gulamhusein S, Ko P, Carruthers G, Klein GJ. Acceleration of ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome. Circulation 65: 348–354, 1982

    Article  PubMed  CAS  Google Scholar 

  • Gulamhusein S, Ko P, Klein GJ. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. American Heart Journal 106: 145–147, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hagemeijer F. Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. Circulation 57: 751–755, 1978

    Article  PubMed  CAS  Google Scholar 

  • Harper RW, Whitford E, Middlebrook K, Federman J, Anderson S, et al. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. American Journal of Cardiology 50: 1323–1330, 1982

    Article  PubMed  CAS  Google Scholar 

  • Heng MK, Singh BN, Roche AHG, Norris RM, Mercer CJ. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. American Heart Journal 90: 487–498, 1975

    Article  PubMed  CAS  Google Scholar 

  • Hoffman BF, Bigger JT. Digitalis and allied cardiac glycosides. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, pp. 729–760 Macmillan, New York, 1980

    Google Scholar 

  • Horio Y, Matsuyama, K, Morikami, Y, Rokutanda M, Hirata A, et al. Blocking effect on verapamil on conduction over a catecholamine-sensitive bypass tract in exercise-induced Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology 4: 186–191, 1984

    Article  PubMed  CAS  Google Scholar 

  • Horowitz LN, Spielman SR, Greenspan AM, Morganroth J, Brady MB, et al. Amiodarone therapy for resistant atrial fibrillation. (Abstract.) Journal of the American College of Cardiology 5: 480, 1985

    Google Scholar 

  • Kawai C, Konishi T, Matsuyama E, Okazaki H. Comparative effects of the three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation 63: 1035–1042, 1981

    Article  PubMed  CAS  Google Scholar 

  • Keefe DL, Harapat SR, Kates RE. Relationship between pharmacodynamics and myocardial concentration of verapamil. (Abstract.) American Journal of Cardiology 47: 406, 1981

    Article  Google Scholar 

  • Kerber RE, Goldman RH, Gianelly RE, Harrison, DC. Treatment of atrial arrhythmias with alprenolol. Journal of the American Medical Association 214: 1849–1854, 1970

    Article  PubMed  CAS  Google Scholar 

  • Kerin N, Benederet D, Blevins R, Garfinkel C, Rubenfire M. Amiodarone in refractory atrial fibrillation. Circulation (Suppl. 2): 11–1754, 1984

  • Khalsa A, Olsson SB. Verapamil-induced ventricular regularity in atrial fibrillation. Acta Medica Scandinavica 205: 509–515, 1979

    Article  PubMed  CAS  Google Scholar 

  • Klein HO, DiSegni E, Kaplinsky, E. Paradoxic acceleration of ventricular rate after therapy with lidocaine and ajmaline. Chest 71:531–533, 1977

    Article  PubMed  CAS  Google Scholar 

  • Klein HO, Pauzner H, DiSegni E, David D, Kaplinsky E. The beneficial effects of verapamil in chronic atrial fibrillation. Archives of Internal Medicine 139: 747–749, 1979

    Article  PubMed  CAS  Google Scholar 

  • Klein HO, Lang R, DiSegni E, Sareli, P, David D, et al. Verapamil — superior to digoxin in the management of chronic atrial fibrillation? Circulation (Suppl.3): 111–84, 1980a

  • Klein HO, Lang R, DiSegni E, Kaplinsky E. Verapamil-digoxin interaction. New England Journal of Medicine 303: 106, 1980b

    Google Scholar 

  • Klein HO, Kapainsky E. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. American Journal of Cardiology 50: 894–902, 1982

    Article  PubMed  CAS  Google Scholar 

  • Klein HO, Lang R, Weiss E, DiSegni E, Libhaber E. et al. The influence of verapamil on serum digoxin concentration. Circulation 65: 998–1003, 1982

    Article  PubMed  CAS  Google Scholar 

  • Klein HO, Ninio R, Oren V, Lang R, Sereli P, et al. The acute hemodynamic effects of intravenous verapamil in coronary artery disease: assessment by equilibrium-gated radionuclide ventriculography. Circulation 67: 101–110, 1983

    Article  PubMed  CAS  Google Scholar 

  • Knox JAC. The heart rate with exercise in patients with auricular fibrillation. British Heart Journal 11: 119–125, 1949

    Article  PubMed  CAS  Google Scholar 

  • Koren G, Soldin S, MacLeod SM. Digoxin-verapamil interaction: in vitro studies in rat tissue. Journal of Cardiovascular Pharmacology 5: 443–445, 1983

    Article  PubMed  CAS  Google Scholar 

  • Kosovsky BD, Haft JI, Lan SH, Stein E, Damato AN. The effects of digitalis on atrioventricular conduction in man. American Heart Journal 75: 736–742, 1968

    Article  Google Scholar 

  • Krikler DM, Spurrell RAJ. Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgraduate Medical Journal 50: 447–453, 1974

    Article  PubMed  CAS  Google Scholar 

  • Lang R, Klein HO, Weiss E, David D, Sareli P, et al. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest 83: 491–499, 1983a

    Article  PubMed  CAS  Google Scholar 

  • Lang R, Klein HO, DiSegni E, Gefen J, Sareli P, et al. Verapamil improves exercise capacity in chronic atrial fibrillation: double blind crossover study. American Heart Journal 105: 820–825, 1983b

    Article  PubMed  CAS  Google Scholar 

  • Lemberg L, Castellanos Jr A, Acerbal AG. The use of propranolol in arrhythmias complicating acute myocardial infarction. American Heart Journal 80: 479–483, 1970

    Article  PubMed  CAS  Google Scholar 

  • Lewis T. Diseases of the heart, p. 90, MacMillan, New York, 1934.

    Google Scholar 

  • Luten D, Jeffreys EO. The clinical significance of auricular fibrillation. Journal of the American Medical Association 107: 2099–2102,1936

    Article  Google Scholar 

  • Mackenzie J. Digitalis. Heart 2: 273–386, 1911

    Google Scholar 

  • Naito M, Mitani I, Ijiri M, Furuno I, Miyairi M, et al. Beneficial effect of intravenous diltiazem on supraventricular tachyarrhythmias. (Abstract). Journal of the American College of Cardiology 5: 481, 1985

    Google Scholar 

  • Opie LH. Drugs and the heart. III: Calcium antagonists. Lancet 1: 806–810, 1980

    Article  PubMed  CAS  Google Scholar 

  • Pedersen KE, Dorph-Pedersen A, Hvidt S, Kitgaard NA, Nielsen-Kudsk F. Digoxin-verapamil interaction. Clinical Pharmacology and Therapeutics 30: 311–317, 1981

    Article  PubMed  CAS  Google Scholar 

  • Pederson KE, Christiansen BD, Kjaer K, Klitgaard NA, Nielsen-Kudsk F. Verapamil-induced changes in dogoxin kinetics and intraerythrocytic sodium concentration. Clinical Pharmacology and Therapeutics 34: 8–13, 1983

    Article  Google Scholar 

  • Petri H, Kafka W, Hall D, Rudolph W. Potential acceleration of the ventricular rate in WPW with atrial fibrillation after verapamil. Circulation 62 (Suppl.3): III–262, 1980

    Google Scholar 

  • Petri H, Kafka W, Hansen W, Rudolph W. Discrepant effect of intravenous and oral verapamil on the ventricular rate in WPW syndrome during atrial fibrillation. Circulation (Suppl. 2): II-1082, 1982

  • Plumb VJ, Karp RB, Kouchoukos NT, Zorn Jr GL, James TN, et al. Verapamil treatment of atrial fibrillation and atrial flutter after open heart surgery. Circulation (Suppl. 3): III-308, 1980

  • Probst P. The influence of propafenon on the accessory pathway in WPW-syndrome (an acute intravenous study). Circulation (Suppl. 2): 11–1757, 1984

  • Redfors A. The effect of different digoxin doses on subjective symptoms and physical working capacity in patients with atrial fibrillation. Acta Medica Scandinavica 190: 307–320, 1971a

    Article  PubMed  CAS  Google Scholar 

  • Redfors, A. Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation. Acta Medica Scandinavica 190: 321–333, 1971b

    Article  PubMed  CAS  Google Scholar 

  • Redfors A. Plasma digoxin concentration — its relationship to digoxin dosage and clinical effects in patients with atrial fibrillation. British Heart Journal 34: 383–391, 1972

    Article  PubMed  CAS  Google Scholar 

  • Ricci DR, Orlick AE, Reitz BA, Mason JW, Stinson EB, et al. Depressant effect of digoxin on atrioventricular conduction in man. Circulation 57: 898–903, 1978

    Article  PubMed  CAS  Google Scholar 

  • Rinkenberger RL, Prystowsky EN, Hegger JJ, Troup PJ, Jackman WM, et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 62: 996–1010, 1980

    Article  PubMed  CAS  Google Scholar 

  • Rosen MR, Wit ALA Hoffman BF. Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effect of digitalis. American Heart Journal 89: 391–399, 1975a

    Article  PubMed  CAS  Google Scholar 

  • Rosen MR, Wit AL, Hoffman BF. Electophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. American Heart Journal 89: 665–673, 1975b

    Article  PubMed  CAS  Google Scholar 

  • Rosen KM, Lau SH, Weiss MB. The effect of lidocaine on atrioventricular and intraventricular conduction in man. American Journal of Cardiology 25: 1–5, 1970

    Article  PubMed  CAS  Google Scholar 

  • Rowland RW. Augmented ventricular rate following verapamil treatment for atrial fibrillation with Wolff-Parkinson-White syndrome. Pediatrics 72: 245–246, 1983

    PubMed  CAS  Google Scholar 

  • Rowland E, McKenna WJ, Harris L, Holt DW, Krikler DM. Amiodarone in the prophylaxis of atrial fibrillation. In Kulbertus et al. (Eds) Atrial fibrillation, pp. 262–271, A.B. Hässle, Mölndal, Sweden, 1982

    Google Scholar 

  • Rowland E, McKenna W, Holt D, Perelman M, Krikler D. Oral amiodarone for the conversion of established atrial fibrillation. Circulation (Suppl. 2): II-1755, 1984

  • Sacks H, Kennelly BM. Verapamil in cardiac arrhythmias. British Medical Journal 2: 716, 1972

    Article  PubMed  CAS  Google Scholar 

  • Schamroth L. Immediate effects of intravenous verapamil on atrial fibrillation. Cardiovascular Research 5: 419–424, 1971

    Article  PubMed  CAS  Google Scholar 

  • Schamroth L. The clinical use of intravenous verapamil. American Heart Journal 100: 1070–1075, 1980

    Article  PubMed  CAS  Google Scholar 

  • Schwartz JB, Keefe D, Kates RE, Kirsten E, Harrison DC. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Circulation 65: 1163–1170 1982.

    Article  PubMed  CAS  Google Scholar 

  • Selzer A. Hemodynamic effects of digitalis. In Dreifus et al. (Eds) Mechanisms and therapy of cardiac arrhythmias, pp. 562–565, Grune and Stratton, New York, 1966

    Google Scholar 

  • Singh BN, Ellrodt G, Peter CT. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15: 169–197, 1978

    Article  PubMed  Google Scholar 

  • Sobel BE, Braunwald E. Cardiac dysrhythmias. In Isselbacher et al. (Eds) Harrison’s principles of internal medicine, pp. 1056, McGraw-Hill, New York, 1980

    Google Scholar 

  • Spann JF, Hurst JW. The recognition and management of heart failure. In Hurst (Ed.) The heart, arteries and veins, pp. 407–451, McGraw Hill, New York, 1982

    Google Scholar 

  • Spurrell RAJ, Krikler DM, Sowton E. Effects of verapamil on electrophysiological properties of anomalous atrioventricular connection in Wolff-Parkinson-White syndrome. British Heart Journal 36: 256–264, 1974a

    Article  PubMed  CAS  Google Scholar 

  • Spurrell RAJ, Krikler DM, Sowton E. Concealed bypasses of the atrioventricular node in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil. American Journal of Cardiology 38: 590–595, 1974b

    Article  Google Scholar 

  • Stern EH, Pitchon R, King BD, Guerrero J, Schneider RR et al. Clinical use of oral verapamil in chronic and paroxysmal atrial fibrillation. Chest 81: 308–311, 1982

    Article  PubMed  CAS  Google Scholar 

  • Stone PH, Antman EM, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: hemodynamic effects and clinical applications. Annals of Internal Medicine 93: 886–904, 1980

    PubMed  CAS  Google Scholar 

  • Sung RJ, Waxman HL, Elser B, Juma Z. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action. Clinical and Investigational Medicine 3: 41–47, 1980a

    CAS  Google Scholar 

  • Sung RJ, Elser B, McAllister RG. Intravenous verapamil for termination of re-entrant supraventricular tachycardias. Annals of Internal Medicine 93: 682–689 1980b

    PubMed  CAS  Google Scholar 

  • Tai DY, Chang M, Svinarich JT, Chiang BN, Sung RJ. Mechanisms of verapamil-induced conduction block in anomalous atrioventricular bypass tracts. Journal of the American College of Cardiology 5: 311–317, 1985

    Article  PubMed  CAS  Google Scholar 

  • Theisen K, Haufe M, Peters J, Theisen F, Jahrmärker H. Effect of the calcium antagonist diltiazem on atrioventricular conduction in chronic atrial fibrillation. American Journal of Cardiology 55: 98–102, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tommaso C, McDonough T, Parker M, Talano JV. Atrial fibrillation and flutter: immediate control and conversion with intravenously administered verapamil. Archives of Internal Medicine 143: 877–881, 1983

    Article  PubMed  CAS  Google Scholar 

  • Vohra J, Hunt D, Sloman G. Clinical experience with verapamil. Medical Journal of Australia 2: 417–421, 1975

    PubMed  CAS  Google Scholar 

  • Waxman HL, Myerburg RJ, Apel R, Sung RJ. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. A double-blind randomized cross-over study. Annals of Internal Medicine 94: 1–6, 1981

    PubMed  CAS  Google Scholar 

  • Weiner R, Bassan MM, Jarchovsky J, Iusim S, Plavnick L. Clinical course of acute atrial fibrillation treated with rapid digitalization. American Heart Journal 105: 223–227, 1983

    Article  PubMed  CAS  Google Scholar 

  • Weinstein W, Plaut J, Katz LN. Limitations of the use of digitalis for ambulatory patients with auricular fibrillation. American Journal of Medicine 199: 498–505, 1940

    Google Scholar 

  • Weiss AT, Lewis BS, Halon DA, Hasin Y, Gotsman MS. The use of calcium with verapamil in the management of supraventricular tachyarrhythmias. International Journal of Cardiology 4: 275–280, 1983

    Article  PubMed  CAS  Google Scholar 

  • Wellens HJJ, Tau SL, Bär FWH, Duren DR, Lie KI et al. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. British Heart Journal 39: 1058–1066, 1977

    Article  PubMed  CAS  Google Scholar 

  • Wit AL, Cranefield PF. The effects of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant A-V nodal tachycardia. Circulation Research 35: 413–425, 1974

    Article  PubMed  CAS  Google Scholar 

  • Wolfson S, Herman MV, Sullivan JM, Gorlin R. Conversion of atrial fibrillation and flutter by propranolol. British Heart Journal 29: 305–309, 1967

    Article  PubMed  CAS  Google Scholar 

  • Zipes DP. Management of cardiac arrhythmias. In Braunwald (Ed). Heart disease, pp. 648–682, W.B. Saunders, Philadelphia, 1984

    Google Scholar 

  • Zipes DP, Fischer JC. Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circulation Research 34: 184–192, 1974

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Meir ‘General Hospital’, Kfar Saba, Israel

    Herman O. Klein & Elieser Kaplinsky

  2. Sackler School of Medicine, Tel Aviv University, Tel Aviv

    Herman O. Klein & Elieser Kaplinsky

Authors
  1. Herman O. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elieser Kaplinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klein, H.O., Kaplinsky, E. Digitalis and Verapamil in Atrial Fibrillation and Flutter. Drugs 31, 185–197 (1986). https://doi.org/10.2165/00003495-198631030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198631030-00001

Keywords

Search

Navigation